Prosecution Insights
Last updated: October 02, 2026
Application No. 18/962,498

DISTALLY GENERATED ULTRASONIC MOTION RESECTION TOOL

Non-Final OA §102
Filed
Nov 27, 2024
Priority
Oct 29, 2019 — provisional 62/927,427 +2 more
Examiner
MILLER, SERENITY A
Art Unit
Tech Center
Assignee
Boston Scientific Corporation
OA Round
1 (Non-Final)
68%
Grant Probability
Favorable
1-2
OA Rounds
1y 1m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
83 granted / 122 resolved
+8.0% vs TC avg
Strong +37% interview lift
Without
With
+36.9%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
30 currently pending
Career history
153
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
44.1%
+4.1% vs TC avg
§102
25.9%
-14.1% vs TC avg
§112
25.1%
-14.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 122 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claims 19-20 are objected to because of the following informalities: Claim 19, line 3 should read “linear movement of the actuator rod…” Claim 20, should read “the end effector comprises a cutting edge.” Appropriate correction is required. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 16, 17, and 20 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Bromfield (US 2009/0236938 A1) Regarding claim 16, Bromfield discloses a medical device (see Fig. 14B), comprising: an elongate sheath (while not shown in Fig. 14B, Bromfield discloses that the transducer system can have a housing, see [0045] and [0067]); an end effector (needle 1406) distal of a distal portion of the elongate sheath (needle 1406 would be distal of the sheath because Bromfield teaches the transducer within the housing); a transducer (1403, 1404, see [0059]) housed within the distal portion of the elongate sheath and proximal to the end effector (at least a portion of the transducer would be within the distal portion of the elongate sheath since as shown in Fig. 17B the proximal portion of the horn forms a seal with the housing, see [0067] and [0069]); and wherein linear actuation of the transducer initiates rotational movement of the end effector (resonator 1403 converts longitudinal motion to torsional motion within the needle, see [0059]). Regarding claim 17, Bromfield discloses the medical device of claim 16, further comprising: a tubular end effector disposed within the distal portion of the elongate sheath and coupled with the end effector (the proximal portion of the horn 1405 that would form a seal with the distal portion of the housing as indicated at element 1705 in Fig. 17B is tubular and coupled to the end effector formed by needle 1406, see also [0067] and [0069]). Regarding claim 20, Bromfield discloses the medical device of claim 16, wherein the end effector comprises a cutting edge (the needle 1406 at the distal end is comprises a cutting edge since it is capable of cutting). Allowable Subject Matter Claims 1-15 are allowed. Claims 18 and 19 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: Regarding claims 1 and 10, Bromfield teaches a medical device (see Fig. 14B), comprising: an elongate sheath (while not shown in Fig. 14B, Bromfield discloses that the transducer system can have a housing, see [0045] and [0067]); a tubular end effector disposed within the distal portion of the elongate sheath (the proximal portion of the horn 1405 that would form a seal with the distal portion of the housing as indicated at element 1705 in Fig. 17B is tubular, see also [0067] and [0069]); a transducer (1403, 1404, see [0059]) housed within the distal portion of the elongate sheath and proximal to the end effector (at least a portion of the transducer would be within the distal portion of the elongate sheath since as shown in Fig. 17B the proximal portion of the horn forms a seal with the housing, see [0067] and [0069]); and an end effector (needle 1406) at a distal end of the tubular end effector (needle 1406 is connected to the distal of the horn 1405, see Fig. 14B). Bromfield fails to teach the elongate sheath is flexible and a compression spring and actuator rod as claimed. Although flexible sheaths, compression springs and actuator rods are known in the art, it would not have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to arrive at the technical solutions of claims 1 and 10 according to any of the prior art documents of record or any combinations thereof. Regarding claims 2-9 and 11-15, the closest prior art documents of record fail to teach the medical device of claims 1 and 10, respectively. Regarding claim 18, the closest prior art document of record, Bromfield, teaches the medical device of claim 17, but fails to teach an actuator rod disposed within the distal portion of the elongate sheath and between the tubular end effector and the transducer, wherein a distal end of the actuator rod is configured to move along a curved slot formed within the tubular end effector. It would not have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify the device of Bromfield to arrive at the technical solutions of claim 18 according to any of the prior art documents of record or any combinations thereof. Regarding claim 19, the closest prior art document of record, Bromfield, teaches the medical device of claim 16, but fails to teach an actuator rod disposed within the distal portion of the elongate sheath, wherein linear movement of the actuator rod results in rotational movement of the end effector. It would not have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify the device of Bromfield to arrive at the technical solutions of claim 19 according to any of the prior art documents of record or any combinations thereof. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. All of the documents cited in the attached PTO-892 teach related medical devices. Particular attention is directed to the following references: Gavala et al. (US 2014/0336665 A1) teaches a medical device (10, see Fig. 1A) having a compression spring (42) disposed between a wall within an elongate sheath (12) and a transducer (14). Hall et al. (US 2011/0282337 A1) teaches a medical device comprising a flexible elongate sheath (80), a tubular end effector disposed in a distal portion of the elongate sheath (see Fig. 3) and an actuator that can comprise a piezoelectric transducer that mechanically communicates with an actuator rod to translate longitudinal and/or rotational motion to the end effector (see [0053] and [0054]). Any inquiry concerning this communication or earlier communications from the examiner should be directed to SERENITY MILLER whose telephone number is (571)272-1155. The examiner can normally be reached Monday-Friday 8:00am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Elizabeth Houston can be reached at (571)272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SERENITY A MILLER/Examiner, Art Unit 3771 /ELIZABETH HOUSTON/Supervisory Patent Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Nov 27, 2024
Application Filed
Aug 13, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12697134
TRANSCATHETER PUNCTURE NEEDLE SYSTEM
4y 4m to grant Granted Aug 04, 2026
Patent 12690862
SURGICAL SUTURE HOLDER
2y 11m to grant Granted Jul 28, 2026
Patent 12690860
APPARATUS, DEVICE, AND METHOD FOR INCREASING FORCE DISTRIBUTION AT SUTURE-TISSUE INTERFACE
2y 0m to grant Granted Jul 28, 2026
Patent 12685849
METHOD AND SYSTEM FOR ABSCESS DRAINAGE
3y 6m to grant Granted Jul 21, 2026
Patent 12660986
Repositionable Tissue-Engagement Member And Associated Systems And Methods
4y 1m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
68%
Grant Probability
99%
With Interview (+36.9%)
2y 11m (~1y 1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 122 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month